Należności Handlowe Zmiana Data
AstraZeneca USD 19.05B 1.49B 2025-12
Autolus Therapeutics Ltd USD 32.53M 32.81M 2025-06
Hikma Pharmaceutical USD 1.08B 27M 2025-12
Novartis USD 8.98B 192M 2025-09
Roche Holding CHF 11.9B 460M 2025-12
Silence Therapeutics USD 22.18M 2.14M 2025-09